Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Bioject sees PATH to developing world market:

This article was originally published in Clinica

Executive Summary

Bioject Medical Technologies is to collaborate with PATH, a Seattle, Washington-based public health organisation, on the development of a needle-free, single-dose cartridge immunisation system. Under the agreement, PATH will evaluate the system using a combination of performance-based bench testing and user focus groups in the developing world. Data from this evaluation will be used to demonstrate the benefits of this technology and reintroduce it to this market, says Bedminster, New Jersey-based Bioject.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts